INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

2,768 studies · page 13 of 116

2018 / Randomized crossover trial

Traditional Malian sorghum and millet foods exhibited substantially slower gastric emptying than other staples.

In a crossover trial, 14 healthy volunteers in Mali tested gastric emptying rates of eight starchy staples using a carbon-13 octanoic acid breath test, followed by a 6-volunteer validation study. Traditional sorghum and millet foods showed gastric half-emptying times approximately twice as long as white rice, potato, or pasta (p < 0.0001). Pre-test assessments ranked millet couscous and rice as more filling, aligning with postprandial hunger ratings.

Cisse F, Erickson DP, Hayes AMR, et al. Nutrients, 2018. PMID 29373493

2018 / Parallel-design randomized controlled trial

A 4-week sleep extension intervention increased sleep duration and reduced free sugar intake in healthy adult short sleepers.

Forty-two normal-weight healthy short sleepers were randomized to a sleep extension group receiving a sleep hygiene behavioral consultation (n = 21) or a control group maintaining habitual short sleep (n = 21) for 4 weeks. Compared with controls, the sleep extension group significantly increased time in bed (0:55 h:mm), sleep period (0:47 h:mm), and sleep duration (0:21 h:mm). Sleep extension led to a significant reduction in free sugar intake (-9.6 g vs. 0.7 g in controls; P = 0.042), with no significant differences observed between groups in markers of energy balance or cardiometabolic health.

Al Khatib HK, Hall WL, Creedon A, et al. Am J Clin Nutr, 2018. PMID 29381788

2018 / Randomized controlled trial

D-allulose supplementation decreased body fat percentage and abdominal fat in overweight adults.

A randomized, double-blind, placebo-controlled trial evaluated d-allulose at 4 g or 7 g twice daily against sucralose in 121 Korean adults with BMI ≥ 23 kg/m². Body fat percentage and body fat mass decreased following allulose supplementation. Compared with placebo, the high-dose group demonstrated significant reductions in BMI along with total abdominal and subcutaneous fat areas on CT scans, with no differences in lipid profiles or nutrient intake.

Han Y, Kwon EY, Yu MK, et al. Nutrients, 2018. PMID 29385054

2018 / Randomized controlled trial

Consecutive and non-consecutive intermittent fasting showed similar hypoglycaemia rates in type 2 diabetes.

Thirty-seven adults with type 2 diabetes completed a 12-week trial testing two weekly very-low-calorie fasting days scheduled either consecutively (n=18) or non-consecutively (n=19). Fasting increased the risk of hypoglycaemia despite medication reduction (RR 2.05, 95% CI 1.17 to 3.52). However, hypoglycaemia rates did not differ significantly between consecutive and non-consecutive fasting regimens (RR 1.54, 95% CI 0.35 to 6.11).

Corley BT, Carroll RW, Hall RM, et al. Diabet Med, 2018. PMID 29405359

2018 / Randomized, placebo-controlled, double-blind parallel trial

Lemon verbena extract supplementation significantly attenuated the loss of muscle strength following exhaustive exercise compared to placebo.

In a double-blind trial, 44 sports-active adults were randomized to receive 400 mg lemon verbena extract (Recoverben®) daily or placebo for 15 days, which included 10 days pre-exercise, the day of an intensive jump protocol, and 4 days post-exercise. Compared to placebo, participants receiving lemon verbena extract experienced significantly less exercise-related loss of muscle strength over all timepoints (p = 0.0311). They also showed a trend toward improved glutathione peroxidase activity (p = 0.0681) and less movement-induced pain (p = 0.0788), whereas creatine kinase and IL-6 did not differ significantly between groups.

Buchwald-Werner S, Naka I, Wilhelm M, et al. J Int Soc Sports Nutr, 2018. PMID 29410606

2018 / Open-label, non-randomized, controlled study

A remote continuous care model using nutritional ketosis significantly reduced HbA1c, body weight, and diabetes medication use at 1 year.

An open-label, non-randomized controlled study evaluated a 1-year continuous care intervention (CCI) delivering remote care, biometric feedback, and nutritional ketosis versus usual care (UC) in adults with type 2 diabetes. In the CCI group, HbA1c declined from 7.6 ± 0.09% to 6.3 ± 0.07%, weight decreased by 13.8 ± 0.71 kg, and non-metformin diabetes medication prescriptions fell from 56.9 ± 3.1% to 29.7 ± 3.0% (all P < 1.0 × 10^-16). Insulin was reduced or stopped in 94% of users, sulfonylureas were eliminated, and improvements were observed in HOMA-IR, hsCRP, and triglycerides, alongside a 10% increase in LDL-C; usual care participants had no significant biomarker or medication changes.

Hallberg SJ, McKenzie AL, Williams PT, et al. Diabetes Ther, 2018. PMID 29417495

2018 / Randomized controlled trial

Moderate sleep restriction reduced the proportion of weight lost as fat during an 8-week caloric restriction regimen, despite similar total weight loss.

Overweight or obese adults were randomized to an 8-week caloric restriction diet alone (CR, n = 15) or combined with sleep restriction on 5 nights per week (CR + SR, n = 21). Both groups had similar total weight, lean mass, and fat mass loss. However, the proportion of total mass lost as fat was significantly greater in the CR group (p = 0.016). Resting respiratory quotient decreased only in CR (p = 0.033), and fasting leptin concentration decreased only in CR + SR (p = 0.029).

Wang X, Sparks JR, Bowyer KP, et al. Sleep, 2018. PMID 29438540

2018 / Repeated-measures test-retest trial

During 24-hour fasts, hunger-related assessment reliability varied and participants averaged 60% subsequent energy compensation.

Eleven participants completed two 24-hour fasts following a 3-day standardized weight-maintenance diet to evaluate test-retest reliability of hunger variables and subsequent energy intake. At 16 hours of fasting, ICCs for all hunger-related assessments were significant (r = 0.67-0.91; p ≤ 0.05), but reliability varied over time, with average ICCs of 0.81 for fullness, 0.74 for prospective food consumption (PFC), 0.67 for energy, 0.44 for desire to eat (DTE), and 0.36 for hunger. Average post-fast energy compensation was 60% of weight-maintenance needs (ranging 7 to 110%) and correlated with changes in PFC, hunger, and DTE, but not body fat percentage. After fasting, percent energy intake from fat and protein increased (29.9% to 37.3% and 13.8% to 16.8%), while carbohydrate intake decreased (56.4% to 46.0%).

Tinsley GM, Moore ML, Graybeal AJ Physiol Behav, 2018. PMID 29438660

2018 / Randomized controlled pilot study

Consuming more energy in the morning significantly increased percent weight loss and sleep onset/wake time regularity compared to evening loading.

An 8-week randomized controlled pilot study examined the impact of energy distribution timing within a hypocaloric, three-meal diet in 8 participants. Participants were assigned to either a Morning pattern (50%, 30%, and 20% of kcal at breakfast, lunch, and dinner) or an Evening pattern (20%, 30%, and 50% of kcal at breakfast, lunch, and dinner). Percent weight loss and regularity of sleep onset and wake times were significantly greater for Morning compared to Evening (p < 0.05). The authors note the need for longer studies in free-living participants with time-stamped dietary assessments.

Raynor HA, Li F, Cardoso C Physiol Behav, 2018. PMID 29471076

2018 / Randomized trial

Following matched 5% weight loss, intermittent energy restriction produced a greater reduction in postprandial TAG responses than continuous energy restriction.

Twenty-seven overweight or obese adults were randomized to intermittent energy restriction (IER, n=15) or continuous energy restriction (CER) until achieving 5% weight loss, followed by 7 days of weight stabilization. There was no significant difference in time to 5% weight loss (median 59 d vs 73 d, P=0.246) or body composition changes between groups. Neither diet significantly altered postprandial glycaemia (P=0.266), and insulinaemia was reduced comparatively (P=0.903). However, IER led to a significantly greater relative reduction in postprandial TAG responses (106 to 68 mmol×360 min/l) compared to CER (117 to 130 mmol×360 min/l; P=0.045), and a trend toward a greater reduction in C-peptide (P=0.057).

Antoni R, Johnston KL, Collins AL, et al. Br J Nutr, 2018. PMID 29508693

2018 / Randomized controlled crossover trial

Caffeine improves cycling endurance only in athletes with the CYP1A2 AA genotype.

In a randomized, double-blind trial, 101 male athletes completed a 10-km cycling time trial with 0, 2, or 4 mg/kg of caffeine. Overall, 4 mg/kg decreased cycling duration by 3% versus placebo (P = 0.01), but a significant caffeine-gene interaction occurred (P < 0.0001). Cycling time decreased at 2 mg/kg (-4.8%) and 4 mg/kg (-6.8%) in AA genotypes, showed no change in AC genotypes, and lengthened by 13.7% at 4 mg/kg in CC genotypes.

Guest N, Corey P, Vescovi J, et al. Med Sci Sports Exerc, 2018. PMID 29509641

2018 / Randomized controlled trial

Twice-daily kiwifruit consumption for 2 months reduced gingival bleeding and attachment loss prior to periodontal treatment.

Participants were randomly assigned to consume two kiwifruits per day for 5 months or no kiwifruit, with initial periodontal treatment (IPT) delivered at 2 months. At 2 months prior to IPT, bleeding score decreased significantly within the kiwifruit group by 6.67% ± 11.90% (P < 0.01), and the kiwifruit group had significantly lower values of bleeding, plaque, and attachment loss compared to controls. After IPT at 5 months, both groups demonstrated clinical benefits, but the control group had significantly greater reductions of bleeding, plaque, and attachment loss than the test group. Systemic biomarkers and vital signs showed no clinically relevant differences between groups.

Graziani F, Discepoli N, Gennai S, et al. J Periodontol, 2018. PMID 29520772

2018 / Double-blind, randomized, placebo-controlled trial

Amla tablets significantly reduced the frequency and severity of heartburn and regurgitation compared to placebo in patients with non-erosive reflux disease.

A double-blind, randomized, placebo-controlled trial evaluated the efficacy of Amla (Phyllanthus emblica L.) tablets in 68 patients with non-erosive reflux disease. Participants took two 500 mg Amla tablets or placebo twice daily after meals for 4 weeks. Heartburn and regurgitation frequencies significantly dropped in both groups (P < 0.001), but repeated measures logistic regression demonstrated a significantly greater reduction in the frequency and severity of both heartburn and regurgitation in the Amla group compared to placebo (P < 0.001).

Karkon Varnosfaderani S, Hashem-Dabaghian F, Amin G, et al. J Integr Med, 2018. PMID 29526236

2018 / Randomized clinical trial (2x2 factorial)

Increasing protein intake from 0.8 to 1.3 g/kg/d did not improve lean body mass or muscle performance in functionally limited older men.

A 2x2 factorial randomized trial assigned 92 functionally limited older men for 6 months to controlled diets of 0.8 or 1.3 g/kg/d of protein, paired with weekly testosterone or placebo. Changes in lean body mass (0.31 kg; 95% CI, -0.46 to 1.08 kg; P = .43), appendicular lean mass, muscle strength, physical function, and well-being did not differ between protein levels, regardless of testosterone use. However, fat mass decreased significantly more with higher protein intake compared to the RDA group (difference, -1.12 kg; 95% CI, -2.04 to -0.21; P = .02).

Bhasin S, Apovian CM, Travison TG, et al. JAMA Intern Med, 2018. PMID 29532075

2018 / Within-subject comparative study with washout

Diet restriction alone achieved similar short-term glycemic and insulin improvements as RYGB combined with the same diet in patients with type 2 diabetes.

Ten patients with type 2 diabetes completed a 10-day supervised peri-operative-equivalent diet intervention, followed by a washout period, and then an identical diet paired with RYGB. Both interventions produced similar improvements in glucose levels, β-cell function, insulin sensitivity, and post-meal hepatic insulin resistance, alongside significant decreases in fasting and postprandial acyl ghrelin. The diet-only period led to greater improvements in basal hepatic glucose output and post-meal GIP secretion, whereas the diet plus RYGB intervention induced significantly greater increases in post-meal GLP-1, PYY, and glucagon levels.

Pop LM, Mari A, Zhao TJ, et al. Diabetes Obes Metab, 2018. PMID 29532631

2018 / Double-blind, crossover, randomized, placebo-controlled trial

Combined resveratrol and curcumin supplementation did not alter the postprandial inflammatory response to a high-fat meal in older adults with abdominal obesity.

In a randomized, double-blind crossover trial, 22 older adults with abdominal obesity underwent a 6-hour oral fat tolerance test after consuming either a supplement (200 mg resveratrol and 100 mg curcumin) or a placebo. Supplementation did not modify postprandial variations in circulating inflammatory markers (CRP, IL-6, IL-8, MCP-1) or adhesion molecules (sE-selectin, sVCAM-1, sICAM-1) compared to placebo (P Treatment×Time > 0.05). However, the supplement significantly reduced the cumulative postprandial response of sVCAM-1 (incremental area under the curve -4643%, P = 0.01), while whole-blood PPARA and NFKB1 gene expressions were unchanged.

Vors C, Couillard C, Paradis ME, et al. J Nutr, 2018. PMID 29546309

2018 / Double-blind, randomized crossover trial

TA-65 supplementation improved HDL-C, LDL/HDL ratio, BMI, waist circumference, and TNF-alpha in patients with metabolic syndrome.

A double-blind, randomized crossover trial evaluated the effects of 16 mg daily of TA-65 (an Astragalus membranaceus extract) versus placebo for 12 weeks with a 3-week washout in 40 patients with metabolic syndrome. Compared to placebo, TA-65 treatment led to significantly higher HDL-C and lower BMI, waist circumference, LDL/HDL ratio, and plasma TNF-alpha (p < 0.05 for all). Changes in HDL-C between periods were negatively correlated with changes in CRP (r = -0.511, p < 0.01), ALT (r = -0.61, p < 0.001), and TNF-alpha (r = -0.550, p < 0.001).

Fernandez ML, Thomas MS, Lemos BS, et al. Curr Pharm Des, 2018. PMID 29546832

2018 / Randomized controlled trial

A vegetarian diet reduced body creatine stores in women, without altering carnitine homeostasis.

Forty omnivorous women followed a control omnivorous diet, an unsupplemented vegetarian diet, or a vegetarian diet with creatine and beta-alanine for six months. Plasma and muscle total creatine dropped significantly by three months in unsupplemented vegetarians, whereas plasma creatine increased in supplemented vegetarians. Dietary changes did not affect carnitine-related measures or unsupplemented muscle carnosine, showing that low-dose creatine supplementation ameliorated the vegetarian-induced decline in the creatine pool.

Blancquaert L, Baguet A, Bex T, et al. Br J Nutr, 2018. PMID 29569535

2018 / Uncontrolled before-and-after intervention study

A 4-week defined plant-based diet reduced blood pressure, serum lipids, and medication usage in an outpatient clinic setting.

Participants in an outpatient cardiovascular clinic consumed a defined plant-based diet excluding all animal products and consisting of raw fruits, vegetables, seeds, and avocado for 4 weeks. Significant reductions were observed in systolic (-16.6 mmHg) and diastolic (-9.1 mmHg) blood pressure (P < 0.0005), serum lipids (P ≤ 0.008), and total medication usage (P < 0.0005). Reductions also occurred in weight (P < 0.0005), waist circumference (P < 0.0005), heart rate (P = 0.018), insulin (P < 0.0005), glycated hemoglobin (P = 0.002), and hs-CRP (P = 0.001).

Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 29575002

2018 / Randomized controlled trial

Sustained calorie restriction over two years induced metabolic adaptation and lowered oxidative stress.

A randomized trial assigned 53 non-obese adults to either approximately 15% calorie restriction (n = 34) or a control group (n = 19) for two years. Participants in the restriction group lost an average of 8.7 kg, while control participants gained 1.8 kg. Measured daily energy expenditure was 80 to 120 kcal lower than predicted from weight loss, accompanied by decreased thyroid axis activity and lower F2-isoprostane levels.

Redman LM, Smith SR, Burton JH, et al. Cell Metab, 2018. PMID 29576535

2018 / Randomized controlled trial

Vegan fecal microbiota transplants did not lower TMAO production in metabolic syndrome.

Twenty men with metabolic syndrome received either autologous or lean vegan-donor fecal transplants. After two weeks, vegan-donor transplants altered microbial community structure toward a vegan profile in some participants. However, the intervention caused no functional changes in TMAO synthesis from choline or carnitine, aortic radiotracer uptake, or cytokine generation from isolated immune cells.

Smits LP, Kootte RS, Levin E, et al. J Am Heart Assoc, 2018. PMID 29581220

2018 / Randomized controlled trial

Powdered Nigella sativa improved body weight, BMI, and lipid profiles in patients with Hashimoto's thyroiditis.

Forty patients with Hashimoto's thyroiditis aged 22-50 were randomized to receive powdered Nigella sativa or placebo daily for 8 weeks. Treatment with Nigella sativa significantly reduced body weight and body mass index, decreased serum LDL and triglyceride concentrations, and significantly increased HDL cholesterol (P < 0.05), while no such changes were seen in the placebo group. Serum Nesfatin-1 was inversely associated with triglycerides (r = -0.31, P = 0.04).

Farhangi MA, Dehghan P, Tajmiri S Lipids Health Dis, 2018. PMID 29587770

2018 / Randomized clinical study

Dietary fibers selectively promoted gut bacteria producing short-chain fatty acids, improving HbA1c levels in patients with type 2 diabetes.

A randomized clinical study of specifically designed isoenergetic diets paired with fecal shotgun metagenomics evaluated the effect of dietary fibers in patients with type 2 diabetes mellitus. Dietary fibers selectively promoted a specific group of short-chain fatty acid (SCFA)-producing strains while diminishing or leaving unchanged most other potential producers. Greater diversity and abundance of these fiber-promoted SCFA producers led to greater improvements in hemoglobin A1c levels, partly through increased glucagon-like peptide-1 production, and diminished bacteria producing detrimental compounds like indole and hydrogen sulfide.

Zhao L, Zhang F, Ding X, et al. Science, 2018. PMID 29590046

2018 / 2 x 6-week randomized, double-blind, placebo-controlled crossover trial

Chronic nicotinamide riboside supplementation is well-tolerated and stimulates NAD+ metabolism in healthy middle-aged and older adults.

In a 2 x 6-week randomized, double-blind, placebo-controlled crossover clinical trial, researchers assessed the effects of chronic supplementation with the NAD+ precursor nicotinamide riboside (NR) in healthy middle-aged and older adults. Chronic NR supplementation was well tolerated and effectively stimulated NAD+ metabolism. The results suggest that future clinical trials should further evaluate the potential benefits of NR for reducing blood pressure and arterial stiffness in this population.

Martens CR, Denman BA, Mazzo MR, et al. Nat Commun, 2018. PMID 29599478